CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Columbus, Ohio, United States and 61 other locations
the return of cancer in patients with a newly diagnosed or recurrent glioblastoma multiforme (GBM) in combination with standard che...
Phase 1, Phase 2
Columbus, Ohio, United States and 4 other locations
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...
Phase 2
Columbus, Ohio, United States and 22 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
Columbus, Ohio, United States and 132 other locations
This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...
Phase 2
Columbus, Ohio, United States and 47 other locations
To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...
Phase 2
Columbus, Ohio, United States and 90 other locations
Clinical trials
Research sites
Resources
Legal